Thiabendazole
Back to searchMolecule Structure
Scientific Name
Thiabendazole
Description of the Drug
Thiabendazole is a benzimidazole used in the treatment of strongyloides, cutaneous larva migrans, visceral larva migrans, and trichinosis infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00730
http://www.drugbank.ca/drugs/DB00730
Brand Name(s)
Equizole, Mintezol, Omnizole, Tiabendazole
Company Owner(s)
Merck Sharp And Dohme Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2364704 |
Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2364705 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL19842 |
PharmGKB | PA164746466 |
Human Metabolome Database | HMDB0014868 |
DrugBank | DB00730 |
PubChem: Thomson Pharma | 15195537 |
PubChem | 5430 |
Mcule | MCULE-3720823189 |
LINCS | LSM-3741 |
Nikkaji | J2.961K |
PDBe | TMG |
BindingDB | 50121347 |
EPA CompTox Dashboard | DTXSID0021337 |
DrugCentral | 2621 |
Brenda | 8423 |
ChemicalBook | CB1685813 |
Guide to Pharmacology | 7304 |
rxnorm | THIABENDAZOLE |
KEGG Ligand | C07131 |
ChEBI | 45979 |
ZINC | ZINC000000073711 |